RE-SCREEN: Optimized Rehabilitation Following Primary Breast Cancer Surgery

Sponsor
Lund University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03434717
Collaborator
(none)
950
1
3
60.5
15.7

Study Details

Study Description

Brief Summary

This study aims to evaluate the effects of an intervention based on systematic screening of psychological distress as the basis for individualised support and rehabilitation following primary breast cancer surgery focusing on psychological , physical and health-economics outcomes. The aim is also to illuminate patients' and relatives' experiences and need of support during the rehabilitation .

Condition or Disease Intervention/Treatment Phase
  • Other: Individualised rehabilitation
  • Other: Care as usual
N/A

Detailed Description

Breast cancer survivors are known to suffer from remaining problems from their treatment after surgery. Despite numerous of studies evaluating the effect of various rehabilitation programs it is know that patients often receive rehabilitation recommendations that are general rather than individualised to their needs. The large amount of studies within this area have contributed to knowledge about potential beneficial rehabilitation interventions for these patients but there is still a lack of knowledge about how patients specific needs of rehabilitation can be identified and how health care can adjust and individualize rehabilitation to optimize rehabilitation. This study aims to evaluate the effects of an intervention based on systematic screening of psychological distress as the basis for individualised support and rehabilitation following primary breast cancer surgery focusing on psychological , physical and health-economics outcomes. The aim is also to illuminate patients' and relatives' experiences and need of support during the rehabilitation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
950 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
RCTRCT
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Optimized Rehabilitation Following Primary Breast Cancer Surgery - Systematic Screening as a Tool for Individualised Rehabilitation: Study Protocol for the RE-SCREEN Randomized Controlled Trial
Actual Study Start Date :
Nov 15, 2018
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control (high distress)

Control group receiving care as usual

Other: Care as usual
Patients will get care as usual

Experimental: Individualised rehabilitation

Patients with high distress receive the intervention "individualized rehabilitation" including evaluation of individual needs and based on that physical, psychological or social interventions to promote rehabilitation.

Other: Individualised rehabilitation
Patients will get access/support to individualised rehabilitation based on their needs identified through the distress thermometer

Experimental: Control group (low distress)

Control group receiving care as usual

Other: Care as usual
Patients will get care as usual

Outcome Measures

Primary Outcome Measures

  1. Psychological Distress [Instrument will be answered approximately 1 week pre-operative and after surgery at 2 weeks, 3 ,6 ,9 and 12 months postoperative. Evaluating change over time.]

    Psychological Distress measured by the "Distress thermometer". A instrument that the patients answer themselves measuring the level of distress and the potential problems the may have.

Secondary Outcome Measures

  1. General Quality of life [Instrument will be answered approximately 1 week pre-operative and after surgery at 2 weeks, 3 ,6 ,9 and 12 months postoperative. Evaluating change over time.]

    The instrument QLQ-C30 is developed by the EORTC (European Organization for Research and Treatment of Cancer) and measurers quality of life

  2. Information needs [Instrument will be answered approximately 1 week pre-operative and after surgery at 2 weeks, 3 ,6 ,9 and 12 months postoperative. Evaluating change over time.]

    The INFO35 instrument is developed by the EORTC and measures the patients perception of information received

  3. Hospital Anxiety depression scale [Instrument will be answered approximately 1 week pre-operative and after surgery at 2 weeks, 3 ,6 ,9 and 12 months postoperative. Evaluating change over time.]

    HADS anxiety and depression scale will be used to measure the patients level of anxiety and depression. Measured with 14 question ranging from 0-3. Higher score indicates more problems.

  4. Resilience [Instrument will be answered approximately 1 week pre-operative and after surgery at 2 weeks, 3 ,6 ,9 and 12 months postoperative. Evaluating change over time.]

    Conner-Davidsson Resilience scale (CD-RISC) will be used to measure patients resilience trough 25 questions ranging from 0-4. Lower scores indicates more problems

  5. Life style changes [Instrument will be answered approximately 1 week pre-operative and after surgery at 2 weeks, 3 ,6 ,9 and 12 months postoperative. Evaluating change over time.]

    Life style changes will be measured by single items concerning exercise (amount hours of physical activity/day), Body mass index (based on weight and length), alcohol (units/glasses/ day) and tobacco habits (yes/no)

  6. Health economics [Evaluations will be conducted after data collection is finished. 6 months and one year after inclusion.]

    Cost-effectiveness analysis will be performed by evaluations of health care consumption (number of and total cost of health care visits) and by evaluating sickness absence (number of days)

  7. Breast cancer specific quality of life [Instrument will be answered approximately 1 week pre-operative and after surgery at 2 weeks, 3 ,6 ,9 and 12 months postoperative. Evaluating change over time.]

    The instrument QLQ-BR23 is developed by the EORTC (European Organization for Research and Treatment of Cancer) and measurers diagnose specific quality of life

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Undergone treatment for primary breast cancer

  • ≤18 years old

  • Ability to communicate in Swedish

  • Written informed consent

Exclusion Criteria:
  • Recurrent disease

  • Palliative diagnosis

  • Pregnancy

  • Prior history of breast cancer

  • Inability to participate in the study due to cognitive impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Skåne university hospital Malmö Sweden

Sponsors and Collaborators

  • Lund University

Investigators

  • Principal Investigator: Marlene Malmström, PhD, Lund university, department of health siences, Lund

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lund University
ClinicalTrials.gov Identifier:
NCT03434717
Other Study ID Numbers:
  • RESCREEN
First Posted:
Feb 15, 2018
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2022